Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Novel Sickle Cell Outreach Program Improves Access to TCD Screening, Vaccines and Hydroxyurea in a Medically Underserved Area

Emily Riehm Meier, MD MSHS, Leticia Brown, MPH, Kisha Hampton, MPH, Ellen Bloom, MPH, CHES, DeAuntae Lawson, MSW, LSW, Sarah A. Hall, MHS, PA-C

Blood (2019) 134 (Supplement_1): 4696.

https://doi.org/10.1182/blood-2019-130209

Published: 2019

Journal Articles

Spatial Distribution of Invasive Pneumococcal Serotypes in West Africa: A Retrospective Analysis to Inform Immunization in Persons with Sickle Cell Disease

Thomas Carsillo, PhD, Kokou Hefoume Amegan-Aho, MD, Andrea Feller, PhD, Avery McIntosh, PhD, Jonathan Spector, MD MPH, Stephen K. Obaro, MD PhD

Blood (2018) 132 (Supplement 1): 3668.

https://doi.org/10.1182/blood-2018-99-119406

Published: 2018

Journal Articles

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

Kirshma Khemani, MD, Molly K Steele, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD, Inci Yildirim, MD PhD MSc FAAP

Blood (2018) 132 (Supplement 1): 3406.

https://doi.org/10.1182/blood-2018-99-119283

Published: 2018

Journal Articles

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Louise Smith, RCN MSc, Elizabeth Ryan, MB ChB, Russell D Keenan, MBChB, PhD FRCP, FRCPath, Rekha Thangavelu, MB ChB FRCP FRCPath

Blood (2018) 132 (Supplement 1): 4927.

https://doi.org/10.1182/blood-2018-99-119768

Published: 2018

Journal Articles

Comparison of Response to Vaccination with PCV 13 in Patients with Multiple Myeloma Versus Healthy Controls

Deep Shah, Shahzad Mustafa, Jonathan Bress, Saad Jamshed, MD

Blood (2017) 130 (Supplement 1): 5418.

https://doi.org/10.1182/blood.V130.Suppl_1.5418.5418

Published: 2017

Journal Articles

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Edmund K. Waller, MD, Brent R. Logan, PhD, Mingwei Fei, MS, Alan Howard, PhD, John R. Wingard, MD, Claudio Anasetti, MD, Cynthia R. Giver, PhD

Blood (2017) 130 (Supplement 1): 1972.

https://doi.org/10.1182/blood.V130.Suppl_1.1972.1972

Published: 2017

Journal Articles

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management

Ilaria Chicca, PhD, Jennifer LJ Heaney, PhD, Gulnaz Iqbal, PhD, Stella Bowcock, MDMA, Tim Planche, MDPhD, Jill Wood, MPH, Kerry Raynes, MSc, Peter Hawkey, FRCPath, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Helen Higgins, MSc, Janet Dunn, PhD, Mark T Drayson, MD PhD

Blood (2017) 130 (Supplement 1): 3036.

https://doi.org/10.1182/blood.V130.Suppl_1.3036.3036

Published: 2017

Journal Articles

Evaluation of a Novel Newborn Screening Follow-up Program for Infants with Sickle Cell Disease

Emily Riehm Meier, MD MSHS, Kisha Hampton, MPH, Ellen Bloom, MPH, CHES, Natalie Duncan, MPH, Chris Roberson, JD, MPH, Angeli Rampersad, MD

Blood (2016) 128 (22): 2344.

https://doi.org/10.1182/blood.V128.22.2344.2344

Published: 2016

Journal Articles

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Michael A Thompson, MD PhD, Martin K Oaks, PhD, John O Richards, PhD, Maharaj Singh, PhD, Thomas S Smith, BS, Karen M Michel, BS, Andinet W Alemu, MD, Michael P. Mullane, MD, Husam S Tarawneh, MD, Angela M Kraut, Kayla J Hamm, Carla Fuentes

Blood (2016) 128 (22): 5607.

https://doi.org/10.1182/blood.V128.22.5607.5607

Published: 2016

Journal Articles

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Mariane De Montalembert, MD, Miguel R. Abboud, MD, Anne Fiquet, MD, Adlette Inati, MD, Jeffrey D. Lebensburger, DO, Normeen Kaddah, MD, Antonio Piga, MD, Baba Inusa, MD, Qin Jiang, MS, Lisa Pereira, BSc, Emilio A. Emini, PhD, William C. Gruber, MD, Alejandra Gurtman, MD, Daniel A. Scott, MD

Blood (2012) 120 (21): 3212.

https://doi.org/10.1182/blood.V120.21.3212.3212

Published: 2012

Journal Articles

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

Ishac Nazi, Ph.D., John G. Kelton, MD, FRCPC, Mark Larche, Ph.D., Denis P. Snider, Ph.D., Jane C. Moore, B.Sc., James W. Smith, B.Sc., Rumi Clare, B.Sc., Diana M. Moffatt, Joecyln Tufts, Donald M. Arnold, MD, MSc.

Blood (2012) 120 (21): 492.

https://doi.org/10.1182/blood.V120.21.492.492

Published: 2012

Journal Articles

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Blood (2011) 118 (21): 3753.

https://doi.org/10.1182/blood.V118.21.3753.3753

Published: 2011

Journal Articles

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Trudy N Small, MD, Ann A. Jakubowski, MD, PhD, Juliet N Barker, MBBS, (Hons), FRACP, Nancy A. Kernan, MD, Susan E Prockop, MD, Christine Scura Iovino, APRN-BC, FNP-C, LeStrange Nicole, NP, Miguel-Angel Perales, MD, Hugo Castro-Malaspina, MD, Guenther Koehne, MD, PhD, Sergio Giralt, MD, Esperanza B Papadopoulos, MD

Blood (2011) 118 (21): 3037.

https://doi.org/10.1182/blood.V118.21.3037.3037

Published: 2011

Journal Articles

T-Cell and B-Cell Responses After Vaccination against Influenza Virus and Pneumococcus in Chronic Phase CML Patients Treated with Tyrosine Kinase Inhibitors.

Hugues de Lavallade, MD, MsC, Melanie Hart, PhD, Ian H Gabriel, Dr, Peter Kelleher, MD, PhD, Abdullah Alsuliman, PhD, Ahmad Khoder, MD, Dragana Milojkovic, MD, Letizia Foroni, Marco Bua, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, John M Goldman, DM, FCRP, David Marin, MD, Katayoun Rezvani, MD, PhD

Blood (2009) 114 (22): 2214.

https://doi.org/10.1182/blood.V114.22.2214.2214

Published: 2009

Journal Articles

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

Carey Clifton, Leigh Ann Vaughan, Catherine Lucid, Sharon Sims, Brian Engelhardt, MD, Wichai Chinratanalab, MD, Adetola A. Kassim, MD, MS, Stacey Goodman, MD, John P. Greer, MD, Friedrich Schuening, MD, Madan Jagasia, MD, MS, Bipin N. Savani, MD

Blood (2009) 114 (22): 3330.

https://doi.org/10.1182/blood.V114.22.3330.3330

Published: 2009

Journal Articles

Compliance with Immunizations in Splenectomized Individuals: A Study of the Splenectomized Hereditary Spherocytosis Population

Rachael F. Grace, MD, Rachel E. Mednick, Ellis J. Neufeld, MD, PhD

Blood (2008) 112 (11): 1316.

https://doi.org/10.1182/blood.V112.11.1316.1316

Published: 2008

Journal Articles

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial

Catherine Cordonnier, MD, Myriam Labopin, Virginie Chesnel, Patricia Ribaud, Rafael De La Camara, MD, Rodrigo Martino, Andrew Ullmann, Terttu Parkkali, Anna Locasciulli, Karima Yakouben, Karlis Pauksens, Hermann Einsele, Dietger Niederwieser, MD, Jane Apperley, Per T. Ljungman, MD, PhD

Blood (2008) 112 (11): 350.

https://doi.org/10.1182/blood.V112.11.350.350

Published: 2008

Journal Articles

Improvement of Myelodysplasia and Partial Correction of panhypogammaglobulinemia after IV IgG Infusions and Splenectomy

A. Majid Shojania, MD

Blood (2008) 112 (11): 5105.

https://doi.org/10.1182/blood.V112.11.5105.5105

Published: 2008

Journal Articles

Vaccine Efficacy Following Autologous Peripheral Blood Stem Cell Transplant for Lymphoma.

Trudy N. Small, MD, Robert D. Rice, RN, Emily McCullagh, Ariela Noy, Tanya Trippett, Steven M. Horwitz, Andrew D. Zelenetz, Craig Moskowitz

Blood (2007) 110 (11): 603.

https://doi.org/10.1182/blood.V110.11.603.603

Published: 2007

Journal Articles

Invasive Streptococcus Pneumoniae Infections in Pediatric Cancer Patients: High Morbidity and Mortality with Several Vaccine Failures.

Lynn Weber, PharmD, Charlet A. Allen, RPh, Patricia Ackerman, BS, Yoav Messinger, MD

Blood (2006) 108 (11): 3321.

https://doi.org/10.1182/blood.V108.11.3321.3321

Published: 2006

NARROW

A Novel Sickle Cell Outreach Program Improves Access to TCD Screening, Vaccines and Hydroxyurea in a Medically Underserved Area

Spatial Distribution of Invasive Pneumococcal Serotypes in West Africa: A Retrospective Analysis to Inform Immunization in Persons with Sickle Cell Disease

Vaccination Adherence in Pediatric Patients Post-Hematopoietic Stem Cell Transplant

No Demonstrable Benefit of Penicillin in a Vaccinated Population of Children with Sickle Cell Disorder

Comparison of Response to Vaccination with PCV 13 in Patients with Multiple Myeloma Versus Healthy Controls

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management

Evaluation of a Novel Newborn Screening Follow-up Program for Infants with Sickle Cell Disease

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

A 2-Dose Schedule of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Given to Children with Sickle Cell Disease Previously Immunized with 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23): Results of a Phase 3 Study

Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

T-Cell and B-Cell Responses After Vaccination against Influenza Virus and Pneumococcus in Chronic Phase CML Patients Treated with Tyrosine Kinase Inhibitors.

Vaccinations Efficacy in Long Term Survivors After Allogeneic Stem Cell Transplantation: Implication of Repeat Vaccinations and Documenting Vaccination Efficacy.

Compliance with Immunizations in Splenectomized Individuals: A Study of the Splenectomized Hereditary Spherocytosis Population

Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial

Improvement of Myelodysplasia and Partial Correction of panhypogammaglobulinemia after IV IgG Infusions and Splenectomy

Vaccine Efficacy Following Autologous Peripheral Blood Stem Cell Transplant for Lymphoma.

Invasive Streptococcus Pneumoniae Infections in Pediatric Cancer Patients: High Morbidity and Mortality with Several Vaccine Failures.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only